Rigel Pharmaceuticals Inc
NASDAQ:RIGL

Watchlist Manager
Rigel Pharmaceuticals Inc Logo
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Watchlist
Price: 20.17 USD -4.27% Market Closed
Market Cap: 360.4m USD

Intrinsic Value

The intrinsic value of one RIGL stock under the Base Case scenario is 35.57 USD. Compared to the current market price of 20.17 USD, Rigel Pharmaceuticals Inc is Undervalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RIGL Intrinsic Value
35.57 USD
Undervaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Rigel Pharmaceuticals Inc

What is Valuation History?
Compare RIGL to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RIGL?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Rigel Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Rigel Pharmaceuticals Inc

Current Assets 146.6m
Cash & Short-Term Investments 77.1m
Receivables 41.5m
Other Current Assets 27.9m
Non-Current Assets 29.4m
PP&E 1.4m
Intangibles 26.5m
Other Non-Current Assets 1.5m
Efficiency

Free Cash Flow Analysis
Rigel Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Rigel Pharmaceuticals Inc

Revenue
203.1m USD
Cost of Revenue
-21m USD
Gross Profit
182m USD
Operating Expenses
-138.1m USD
Operating Income
43.9m USD
Other Expenses
-6.8m USD
Net Income
37.2m USD
Fundamental Scores

RIGL Profitability Score
Profitability Due Diligence

Rigel Pharmaceuticals Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
41/100
Profitability
Score

Rigel Pharmaceuticals Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

RIGL Solvency Score
Solvency Due Diligence

Rigel Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
High D/E
37/100
Solvency
Score

Rigel Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RIGL Price Targets Summary
Rigel Pharmaceuticals Inc

Wall Street analysts forecast RIGL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RIGL is 34.42 USD with a low forecast of 20.65 USD and a high forecast of 59.85 USD.

Lowest
Price Target
20.65 USD
2% Upside
Average
Price Target
34.42 USD
71% Upside
Highest
Price Target
59.85 USD
197% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Rigel Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RIGL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

RIGL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one RIGL stock?

The intrinsic value of one RIGL stock under the Base Case scenario is 35.57 USD.

Is RIGL stock undervalued or overvalued?

Compared to the current market price of 20.17 USD, Rigel Pharmaceuticals Inc is Undervalued by 43%.

Back to Top